Clinical trial
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
NCT00403650 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00403650 |
|---|---|
| Title | Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension |
| Official title | Inhaled Iloprost for Sarcoidosis Associated Pulmonary Hypertension |
| Lead sponsor | University of Cincinnati, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sarcoidosis, Pulmonary Arterial Hypertension |
| Intervention type | Drug |
| Interventions | Iloprost |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 27, 2006 |
| Last update posted | Apr 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: